Mark Jacobson | Investor Relations |
Herriot Tabuteau | Chief Executive Officer |
Nick Pizzie | Chief Financial Officer |
Lori Englebert | Executive Vice President, Commercial and Business Development |
Charles Duncan | Cantor Fitzgerald |
Marc Goodman | SVB Securities |
David Amsellem | Piper Sandler |
Joon Lee | Truist Securities |
Vikram Purohit | Morgan Stanley |
Yatin Suneja | Guggenheim Partners |
Joseph Thome | TD Cowen |
Graig Suvannavejh | Mizuho Securities |
Myles Minter | William Blair |
Matt Kaplan | Ladenburg Thalmann |
Boobalan Pachaiyappan | H.C. Wainwright |
Hello and welcome to the Axsome Therapeutics First Quarter 2023 Financial Results Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded. It’s now my pleasure to turn the call over to Mark Jacobson. Please go ahead, Mark.
Thank you, operator.